Business News Distributed by GlobeNewswire
Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia
HELSINKI, March 12, 2026 (GLOBE NEWSWIRE) — Aplagon, a clinical stage biotech pioneering a first-in-class …